The impact of an educational DVD on cancer patients considering participation in a phase I clinical trial

Supportive Care in Cancer

Volumn 15, Issue 7, 2007, Pages 829-840

  Strevel, Elizabeth L ^a,b   Newman, Colin ^b   Pond, Gregory R ^b   MacLean, Martha ^a,b   Siu, Lillian L ^a,b  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Education; Informed consent; Phase I clinical trials

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFORMED CONSENT; INTERVIEW; MALE; MEDICAL INFORMATION; PATIENT ATTITUDE; PATIENT DECISION MAKING; PATIENT PARTICIPATION; PATIENT REFERRAL; PHYSICIAN; PRIORITY JOURNAL; QUESTIONNAIRE; VIDEOTAPE;

ANTINEOPLASTIC AGENTS; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT SATISFACTION; PERCEPTION; PROGRAM EVALUATION; VIDEOTAPE RECORDING;

EID: 34548582182     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-006-0199-2     Document Type: Article

References (33)

1. Agrawal M, Emanuel EJ (2003) Ethics of phase I oncology studies: Reexamining the arguments and data. JAMA 290:1075-1082
2. Bain NS, Campbell NC, Ritchie LD et al (2002) Striking the right balance in colorectal cancer care-a qualitative study of rural and urban patients. Fam Pract 19:369-374
3. Cheng JD, Hitt J, Koczwara B et al (2000) Impact of quality of life on patient expectations regarding phase I clinical trials. J Clin Oncol 18:421-428
4. Daugherty CK, Banik DM, Janish L et al (2000) Quantitative analysis of ethical issues in phase I trials: a survey interview study of 144 advanced cancer patients. IRB 22:6-14
5. Daugherty C, Ratain MJ, Grochowski E et al (1995) Perceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol 13:1062-1072
6. Decoster G, Stein G, Holdener EE (1990) Responses and toxic deaths in phase I clinical trials. Ann Oncol 1:145-181
7. Eisenhauer EA, O'Dwyer PJ, Christian M et al (2000) Phase I clinical trial design in cancer drug development. J Clin Oncol 18:684-692
8. Emanuel EJ (1995) A phase I trial on the ethics of phase I trials. J Clin Oncol 13:1049-1051
9. Faden RR, Beauchamp TL, King NMP (1986) A history and theory of informed consent. Oxford University Press, New York, NY
10. Flory J, Emanuel E (2004) Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA 292:1593-1601
11. Fureman I, Meyers K, McLellan AT et al (1997) Evaluation of a video-supplement to informed consent: injection drug users and preventive HIV efficacy trials. AIDS Educ Prev 9:330-341
12. Hlubocky FJ, Kass NE, Fogarty LA et al (2004) Effects of a CD-ROM educational intervention (CD) on prognosis understanding among advanced cancer patients (acp) enrolling in early phase clinical trials. Proc Am Soc Clin Oncol 22:532s (Abstract 6054)
13. Horstmann E, McCabe MS, Grochow L et al (2005) Risks and benefits of phase 1 oncology trials, 1991 through 2002. N Engl J Med 352:895-904
14. Hutchison C (1998) Phase I trials in cancer patients: participants' perceptions. Eur J Cancer Care 7:15-22
15. Hutchison C, Campbell S (2002) Evaluation of an information booklet for patients considering participation in phase I clinical trials in cancer. Eur J Cancer Care 11:131-138
16. Itoh K, Sasaki Y, Fujii H et al (1997) Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations. Br J Cancer 76:107-113
17. Itoh K, Sasaki Y, Miyata Y et al (1994) Therapeutic response and potential pitfalls in phase I clinical trials of anticancer agents conducted in Japan. Cancer Chemother Pharmacol 4:451-454
18. Joffe S, Miller FG (2006) Rethinking risk-benefit assessment for phase I cancer trials. J Clin Oncol 24:2987-2990
19. Meade CD (1999) Improving understanding of the informed consent process and document. Sem Oncol Nurs 15:124-137
20. Meropol NJ, Weinfurt KP, Burnett CB et al (2003) Perceptions of patients and physicians regarding phase I cancer clinical trials: implications for physician-patient communication. J Clin Oncol 21:2589-2596
21. Nitschke R (2004) Physician-patient communication in phase I cancer trials. J Clin Oncol 22:571-572
22. Nurgat ZA, Craig W, Campbell NC et al (2005) Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy. Br J Cancer 92:1001-1005
23. Penman DT, Holland JC, Bahna GF et al (1984) Informed consent for investigational chemotherapy: patients' and physicians' perceptions. J Clin Oncol 2:849-855
24. Rajagopal S, Goodman PJ, Tannock IF (1994) Adjuvant chemotherapy for breast cancer: discordance between physicians' perception of benefit and the results of clinical trials. J Clin Oncol 12:1296-1304
25. Roberts Jr TG, Goulart BH, Squitieri L et al (2004) Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials. JAMA 292:2130-2140
26. Rodenhuis S, van den Heuvel WJA, Annyas AA et al (1984) Patient motivation and informed consent in a phase I study of an anticancer agent. Eur J Cancer Clin Oncol 20:457-462
27. Rossi M, McClellan R, Chou L et al (2004) Informed consent for ankle fracture surgery: patient comprehension of verbal and videotaped information. Foot Ankle Int 25:756-762
28. Von Hoff DD, Turner J (1991) Response rates, duration of response, and dose response effects in phase I studies of antineoplastics. Invest New Drugs 9:115-122
29. Weeks JC, Cook EF, O'Day SJ et al (1998) Relationship between cancer patients' predictions of prognosis and their treatment preferences. JAMA 279:1709-1714
30. Weinfurt KP, Castel LD, Li Y et al (2003) The correlation between patient characteristics and expectations of benefit from phase I clinical trials. Cancer 98:166-175
31. Weston J, Hannah M, Downes J (1997) Evaluating the benefits of a patient information video during the informed consent process. Patient Educ Couns 30:239-245
32. Wirshing DA, Sergi MJ, Mintz J (2005) A videotape intervention to enhance the informed consent process for medical and psychiatric treatment research. Am J Psychiatr 162:186-188
33. Yoder LH, O'Rourke TJ, Etnyre A et al (1997) Expectations and experiences of patients with cancer participating in phase I clinical trials. Oncol Nurs Forum 24:891-896